Recent Quotes
My Watchlist
Indicators
Markets
Stocks
Funds
Tools
Overview
News
Currencies
International
Treasuries

Axsome Thera (NQ: AXSM )

68.07 USD -0.62 (-0.90%)
Official Closing Price Updated: 5:11 PM EDT, Oct 27, 2020 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 205,138
Open 68.69
Bid (Size) 67.75 (2)
Ask (Size) 68.50 (6)
Prev. Close 68.69
Today's Range 67.51 - 69.36
52wk Range 20.48 - 109.94
Shares Outstanding 25,685,492
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year

Top News

More News
Axsome Therapeutics Announces $225 Million Term Loan Facility with Hercules Capital
From GlobeNewswire News Releases
Axsome Therapeutics Presents New Data from MOMENTUM Phase 3 Trial with AXS-07 Demonstrating Rapid Onset of Action and Reduced Symptom Recurrence in the Acute Treatment of Migraine
From GlobeNewswire News Releases

Performance

YTD
-32.81%
-32.81%
1 Month
-10.97%
-10.97%
3 Month
-11.80%
-11.80%
6 Month
-28.35%
-28.35%
1 Year
+196.34%
+196.34%

More News

Read More
Axsome Therapeutics Announces Expedited Development of AXS-12 for the Treatment of Narcolepsy Based on FDA Breakthrough Therapy Meeting
From GlobeNewswire News Releases
Axsome Therapeutics Announces AXS-07 Phase 3 Migraine Trial Results Selected by the American Academy of Neurology Science Committee as Featured Presentation
From GlobeNewswire News Releases
Axsome Therapeutics Presents New Data from GEMINI Phase 3 Trial with AXS-05 Demonstrating Rapid and Significant Improvements in Patient-Reported Outcomes in Major Depressive Disorder
From GlobeNewswire News Releases
Axsome Therapeutics to Present New Data for AXS-05 in Major Depressive Disorder at the 33rd European College of Neuropsychopharmacology Congress
From GlobeNewswire News Releases
Notable Monday Option Activity: XPO, AXSM, MGNI
Tags Stocks
From Market News Video
Axsome Therapeutics to Present at the Morgan Stanley 18th Annual Global Healthcare Conference
From GlobeNewswire News Releases
Analysts Forecast 15% Upside For The Holdings of ESML
Tags ETFs
From ETF Channel
Axsome Therapeutics to Present at Upcoming Investor Conferences
From GlobeNewswire News Releases
Axsome Therapeutics Larger Than S&P 500 Component Under Armour
Tags Stocks
From Market News Video
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.